Two Sigma Investments LP acquired a new position in shares of Quanterix Co. (NASDAQ:QTRX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 56,962 shares of the company's stock, valued at approximately $606,000. Two Sigma Investments LP owned approximately 0.15% of Quanterix at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. Resona Asset Management Co. Ltd. acquired a new position in shares of Quanterix during the 4th quarter valued at $55,000. Tower Research Capital LLC TRC boosted its position in Quanterix by 219.1% during the fourth quarter. Tower Research Capital LLC TRC now owns 5,702 shares of the company's stock valued at $61,000 after purchasing an additional 3,915 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new stake in shares of Quanterix during the 4th quarter worth about $66,000. Canada Pension Plan Investment Board grew its position in Quanterix by 64.5% in the fourth quarter. Canada Pension Plan Investment Board now owns 10,200 shares of the company's stock worth $108,000 after acquiring an additional 4,000 shares in the last quarter. Finally, ProShare Advisors LLC acquired a new stake in shares of Quanterix in the fourth quarter worth about $108,000. Institutional investors own 86.48% of the company's stock.
Analysts Set New Price Targets
Several equities research analysts have recently issued reports on the stock. Scotiabank restated an "outperform" rating on shares of Quanterix in a research note on Tuesday, March 25th. Leerink Partnrs lowered Quanterix from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. Wall Street Zen cut shares of Quanterix from a "hold" rating to a "sell" rating in a research report on Thursday, May 22nd. Leerink Partners restated a "market perform" rating and issued a $8.00 target price (down previously from $12.00) on shares of Quanterix in a research note on Wednesday, April 30th. Finally, Canaccord Genuity Group lowered their price objective on shares of Quanterix from $15.00 to $12.00 and set a "buy" rating on the stock in a research note on Tuesday, May 13th. One research analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, Quanterix presently has a consensus rating of "Hold" and an average target price of $15.60.
Check Out Our Latest Research Report on QTRX
Quanterix Stock Down 7.1%
QTRX traded down $0.47 during trading on Thursday, hitting $6.19. 730,792 shares of the company traded hands, compared to its average volume of 591,634. Quanterix Co. has a one year low of $4.05 and a one year high of $19.18. The stock's fifty day moving average is $5.30 and its 200 day moving average is $7.85. The firm has a market cap of $240.35 million, a P/E ratio of -5.84 and a beta of 1.05.
Quanterix (NASDAQ:QTRX - Get Free Report) last announced its quarterly earnings results on Monday, May 12th. The company reported ($0.53) EPS for the quarter, beating analysts' consensus estimates of ($0.69) by $0.16. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. The company had revenue of $30.33 million for the quarter, compared to analysts' expectations of $28.27 million. On average, equities research analysts forecast that Quanterix Co. will post -0.98 EPS for the current fiscal year.
Insiders Place Their Bets
In other news, Director David R. Walt bought 78,131 shares of the firm's stock in a transaction that occurred on Monday, June 9th. The shares were acquired at an average price of $5.34 per share, with a total value of $417,219.54. Following the acquisition, the director now owns 1,706,933 shares of the company's stock, valued at approximately $9,115,022.22. The trade was a 4.80% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, Director William P. Donnelly purchased 93,113 shares of Quanterix stock in a transaction dated Friday, June 6th. The shares were purchased at an average price of $5.44 per share, with a total value of $506,534.72. Following the completion of the transaction, the director now directly owns 139,094 shares in the company, valued at approximately $756,671.36. This represents a 202.50% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased a total of 303,113 shares of company stock worth $1,639,803 over the last 90 days. Corporate insiders own 6.90% of the company's stock.
About Quanterix
(
Free Report)
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Recommended Stories

Before you consider Quanterix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quanterix wasn't on the list.
While Quanterix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.